Ambroxol showed no clear difference in incidence of RDS frequency in newborns compared with corticosteroid (betamethasone) (moderate certainty).
Ambroxol showed no clear difference in perinatal mortality frequency of deaths of newborns compared with corticosteroid (betamethasone) (moderate certainty).
It is very uncertain whether ambroxol changes adverse effects in pregnant women frequency in pregnant women compared with corticosteroid (betamethasone) (very low certainty).
Ambroxol showed no clear difference in incidence of RDS frequency in newborns compared with placebo or no treatment (low certainty).
Ambroxol showed no clear difference in perinatal mortality frequency of deaths of newborns compared with placebo or no treatment (low certainty).
Ambroxol showed no clear difference in adverse effects in pregnant women frequency in pregnant women compared with placebo or no treatment (low certainty).
Ambroxol showed no clear difference in other events in newborns ‐ Administration of pulmonary surfactant… compared with placebo or no treatment (low certainty).
Ambroxol showed no clear difference in other events in newborns ‐ Need for mechanical ventilation frequency… compared with placebo or no treatment (low certainty).